Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Sunitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 16 Gastrointestinal Stromal Tumors 7 Neoplasms 4 Multiple Myeloma 3 Kidney Neoplasms 3 Urologic Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Kidney Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thoracic Neoplasms 1 Somatostatinoma 1 Solid Tumors Refractory to Standard Therapy 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1 Pelvic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Nervous System Neoplasms 1

Interventions

pembrolizumab 31 Cisplatin 28 Carboplatin 15 Radiotherapy 14 Paclitaxel 14 Bevacizumab 14 Brachytherapy 13 Colposcopy 11 Specimen Handling 10 Nivolumab 10 Blood Specimen Collection 10 Gemcitabine 9 Radiation 8 Magnetic Resonance Spectroscopy 8 Human Papillomavirus DNA Tests 8 Drug Therapy 8 lenvatinib 6 atezolizumab 6 Platinum 6 dostarlimab 5 Radiotherapy, Intensity-Modulated 5 Methods 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 zimberelimab 4 toripalimab 4 spartalizumab 4 Topotecan 4 Restraint, Physical 4 Pemetrexed 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡